Viewing Study NCT01404169


Ignite Creation Date: 2025-12-24 @ 11:14 PM
Ignite Modification Date: 2026-01-04 @ 6:33 PM
Study NCT ID: NCT01404169
Status: COMPLETED
Last Update Posted: 2017-03-08
First Post: 2011-07-26
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A 24-weeks, Multi-center, Randomized, Double-blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of Donepezil Hydrochloride in Chinese Subjects With Severe Alzheimer's Disease
Sponsor: Eisai Limited
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Alzheimer's Type Dementia View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Alzheimer Disease View
None Dementia View
None Delirium View
None Amnestic View
None Cognitive Disorders View
None Donepezil View
None Brain Diseases View
None Central Nervous System Diseases View
None Nervous System Diseases View
None Tauopathies View
None Neurodegenerative Diseases View
None Mental Disorders View
None Cholinesterase Inhibitors View
None Enzy View